In accordance with the expression of DRP1 and MFN2, the average mitochondrial length was significantly increased in these cells, supporting again that mitochondrial dynamics contribute to the development of cisplatin resistance in ovarian cancer cells [122]. This evidence concerns the gene DNM1L and ovarian cancer.